Sezary Syndrome (Sezary Erythroderma) Summary

Networked: 123 relevant articles (10 outcomes, 12 trials/studies) for this Disease

Key Drugs and Agents for Sezary Syndrome

1. vorinostat (suberoylanilide hydroxamic acid) : 2 outcomes 1 study in 3 results : FDA 1
   
2. Complementarity Determining Regions (Complementarity Determining Region) : 1 outcome 1 study in 1 result : IBA
   
3. Interferon-alpha (Interferon Alfa) : 1 outcome in 4 results : FDA 2
   
4. bexarotene (LGD1069) : 1 outcome in 3 results : FDA 2
   
5. Pentostatin (Nipent) : 1 outcome in 2 results : FDA 2 Generic
   
6. Cyclophosphamide (Cytoxan) : 1 outcome in 2 results : FDA 10 Generic
   
7. erlotinib (CP 358,774) : 1 outcome in 1 result : FDA 1
   
8. aprepitant (Emend) : 1 outcome in 1 result : FDA 2
   
9. DNA (Deoxyribonucleic Acid) : 1 study in 9 results : IBA
   
10. T-Cell Antigen Receptors (T-Cell Receptor) : 1 study in 7 results : IBA
    

Diseases Related to Sezary Syndrome

1. Mycosis Fungoides
2. Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
3. B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
4. Graft vs Host Disease (Graft-Versus-Host Disease)
5. Autoimmune Diseases (Autoimmune Disease)

Key Therapies for Sezary Syndrome

1. Photopheresis : 5 outcomes 1 study in 12 results
   
2. Transplants (Transplant) : 1 outcome in 3 results
   
3. Bone Marrow Transplantation (Transplantation, Bone Marrow) : 1 outcome in 1 result
   
4. Biological Therapy : 1 outcome in 1 result
   
5. Photochemotherapy (Photodynamic Therapy) : 1 study in 3 results